SEARCH

SEARCH BY CITATION

References

  • Bekker LG, Orrell C, Reader L et al. (2003) Antiretroviral therapy in a community clinic – early lessons from a pilot project. South African Medical Journal 93, 458462.
  • Bekker LG, Myer L, Orrell C, Lawn S & Wood R (2006) Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa. South African Medical Journal 96, 315320.
  • Boulle A, Bock P, Osler M et al. (2008) Antiretroviral therapy and early mortality in South Africa. Bulletin of the World Health Organization 86, 678687.
  • Box TL, Olsen M, Oddone EZ & Keitz SA (2003) Healthcare access and utilization by patients infected with human immunodeficiency virus: does gender matter? Journal of Women’s Health 12, 391397.
  • Braitstein P, Brinkhof M, Dabis F et al. (2006) Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367, 817824.
  • Braitstein P, Boulle A, Nash D et al. (2008) Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. Journal of Women’s Health 17, 4755.
  • Chen SC, Yu JK, Harries AD et al. (2008) Increased mortality of male adults with AIDS related to poor compliance to antiretroviral therapy in Malawi. Tropical Medicine and International Health 13, 513519.
  • Collazos J, Asensi V & Carton JA (2007) Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART. Aids 21, 835843.
  • Ferradini L, Jeannin A, Pinoges L et al. (2006) Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet 367, 13351342.
  • Hacker MA, Petersen ML, Enriquez M & Bastos FI (2004) Highly active antiretroviral therapy in Brazil: the challenge of universal access in a context of social inequality. Revista Panamericana de Salud Publica 16, 7883.
  • Hogg RS, Yip B, Chan KJ et al. (2001) Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA 286, 25682577.
  • Jahn A, Floyd S, Crampin AC et al. (2008) Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet 371, 16031611.
  • Keiser O (2008) Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in Sub-Saharan Africa, Asia and Latin America. The ART-LINC Collaboration of the International Databases to Evaluate AIDS (IeDEA). Tropical Medicine and International Health 13, 110.
  • Lawn S & Wood R (2006) How can earlier entry of patients into antiretroviral programs in low-income countries be promoted? Clinical Infectious Diseases 42, 431432.
  • Lawn SD, Myer L, Orrell C, Bekker LG & Wood R (2005) Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. Aids 19, 21412148.
  • Lawn SD, Myer L, Harling G, Orrell C, Bekker LG & Wood R (2006) Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clinical Infectious Diseases 43, 770776.
  • Marais BJ, Esser M, Godwin S, Rabie H & Cotton MF (2008) Poverty and human immunodeficiency virus in children: a view from the Western Cape, South Africa. Annals of the New York Acad Sci 1136, 2127.
  • Muula AS, Ngulube TJ, Siziya S et al. (2007) Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review. BMC Public Health 7, 63.
  • Myer L, Ehrlich RI & Susser ES (2004) Social epidemiology in South Africa. Epidemiologic Reviews 26, 112123.
  • Nicastri E, Angeletti C, Palmisano L et al. (2005) Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy. Aids 19, 577583.
  • Nicastri E, Leone S, Angeletti C et al. (2007) Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review. The Journal of Antimicrobial Chemotherapy 60, 724732.
  • Orrell C, Bangsberg DR, Badri M & Wood R (2003) Adherence is not a barrier to successful antiretroviral therapy in South Africa. Aids 17, 13691375.
  • Rosen S, Fox MP & Gill CJ (2007) Patient retention in antiretroviral therapy programs in Sub-Saharan Africa: a systematic review. PLoS Medicine 4, e298.
  • Schwabe C (2004) Fact Sheet: Poverty in South Africa. Human Sciences Research Council, Pretoria. Available at:http://www.sarpn.org.za/documents/d0000990/ (Accessed 14 September 2008).
  • Seyler C, Anglaret X, Dakoury-Dogbo N et al. (2003) Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Cote d’Ivoire. Antiviral Therapy 8, 385393.
  • Stringer JS, Zulu I, Levy J et al. (2006) Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 296, 782793.
  • UNFPA, State of World Population 2003: Making 1 billion count: Investing in Adolescents’ Health and Rights. UNFPA, New York. Available at:http://www.unfpa.org/swp/2003/english.html (Accessed 20 August 2008).
  • Weidle PJ, Malamba S, Mwebaze R et al. (2002) Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients’ response, survival, and drug resistance. Lancet 360, 3440.
  • Western Cape Provincial Department of Health (2007) HIV Prevalence in the Western Cape: Results of the 2006 HIV Antenatal Provincial and Area Surveys. WCPDH, Cape Town .
  • WHO, UNAIDS & UNICEF (2008) Towards Universal Access: Scaling up Priority HIV/AIDS Interventions in the Health Sector: Progress Report: 2008. WHO, Geneva.
  • Yu JK, Chen SC, Wang KY et al. (2007) True outcomes for patients on antiretroviral therapy who are ‘lost-to-follow-up’ in Malawi. Bulletin of the World Health Organization 85, 550554 .